Nephroprotective Effect of Embryonic Stem Cells Reducing Lipid Peroxidation in Kidney Injury Induced by Cisplatin

Monica Maribel Mata-Miranda1, Carlos Eduardo Bernal-Barquero2, Adriana Martinez-Cuazitl1

  • 1Escuela Militar de Medicina, Centro Militar de Ciencias de la Salud, Secretaria de la Defensa Nacional, Ciudad de México 11200, Mexico.

Abstract

Insights

Mouse embryonic stem cells (mESC) protect against cisplatin-induced acute kidney injury (AKI). mESC treatment reduced oxidative stress and lipid peroxidation, preserving kidney structure and function.

Area of Science:

  • Nephrology
  • Stem Cell Biology
  • Biochemistry

Background:

  • Acute kidney injury (AKI) involves sudden glomerular filtration reduction, often caused by nephrotoxic agents like cisplatin.
  • Cisplatin induces AKI through oxidative stress, altering biochemical processes and leading to apoptosis.
  • Embryonic stem cells (ESC) are investigated for their potential nephroprotective effects against AKI.

Purpose of the Study:

  • To analyze the nephroprotective effect of mouse embryonic stem cells (mESC) in cisplatin-induced AKI.
  • To evaluate the impact of mESC on genetic, phenotypic, and microspectroscopic changes in AKI models.
  • To assess the potential of mESC in mitigating cisplatin-induced kidney damage.

Main Methods:

  • Thirty mice were divided into healthy, isotonic salt solution (ISS), and mESC groups.
  • AKI was induced using cisplatin; ISS or mESC were administered intraperitoneally 24 hours post-AKI.
  • Histopathological, genetic (PDK4, HO-1), protein (p53), and microspectroscopic analyses were performed at days 4 and 8 post-AKI.

Main Results:

  • The mESC group exhibited a more preserved renal microarchitecture compared to the ISS group.
  • Gene expression (PDK4, HO-1) and p53 immunoexpression increased in the ISS group, indicating cellular stress.
  • Microspectroscopy revealed reduced lipid peroxidation and improved membrane function in the mESC group, suggesting oxidative stress mitigation.

Conclusions:

  • mESC implantation effectively diminishes cisplatin-induced nephrotoxicity.
  • The protective effect is attributed to the reduction of lipid peroxidation, indicating functional and histological restoration.
  • mESC therapy holds promise for treating AKI caused by nephrotoxic agents.

Related Concept Videos

Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.8K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.5K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
642
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
982